Eribulin Mesylate 71731-4171
Product NDC
71731-4171- Manufacturer
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 4, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA218743
Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eribulin Mesylate | .5 mg/mL |
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1 VIAL, SINGLE-DOSE